Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations

John D. Ayres

doi:10.5731/pdajpst.2018.008615

Article CommentaryCommentary

Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations

John D. Ayres

PDA Journal of Pharmaceutical Science and Technology November 2018, 72 (6) 626-639; DOI: https://doi.org/10.5731/pdajpst.2018.008615

John D. Ayres

Pharma Safety Solutions, LLC, IN, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: jayres1790@gmail.com

Article
References
Info & Metrics
PDF

Article Information

vol. 72 no. 6 626-639

DOI

https://doi.org/10.5731/pdajpst.2018.008615

PubMed

30158238

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online December 4, 2018.

Article Versions

previous version (August 29, 2018 - 07:12).
You are viewing the most recent version of this article.

Author Information

John D. Ayres*

Pharma Safety Solutions, LLC, IN, USA.

↵*Corresponding Author: Pharma Safety Solutions, LLC, 16333 Valhalla Drive, Noblesville, IN 46060, USA; e-mail: jayres1790{at}gmail.com

View Full Text

Cited By...

4 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

An Interlaboratory Study to Identify Potential Visible Protein-Like Particle Standards

Srivalli N. Telikepalli, Michael J. Carrier, Dean C. Ripple, Greg Barnett, Ashwinkumar Bhirde, Donna Bolton, George M. Bou-Assaf, Erica Ferrari, Scott Leigh, Sophia Levitskaya-Seaman, Tim Menzen, Felix Nikels, Anna Riley, Miguel Saggu, Neha Sahni, Eric Vernooij, Klaus Wuchner

AAPS PharmSciTech 2022 24 1
Drug compatibility with various closed intravenous infusion containers

Chang-yu Zhu, Hui-ying Zuo, Hong-lin Li, Rong-sheng Tong

Frontiers in Pharmacology 2024 14
Metal Particle Detection Methods and Their Use for Freeze-Dried Vaccine Inspection: A Review

Jack B. Jedlicki, Denise Tellbach, Brian Subirana

IEEE Sensors Journal 2024 24 1
Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations

Alexandre Jambon, Marie Forat, Chloé Marchand, Corinne Morel, Camille Merienne, Samira Filali, Fabrice Pirot

European Journal of Hospital Pharmacy 2024

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 72, Issue 6

November/December 2018

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 13 + 6 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations

John D. Ayres

PDA Journal of Pharmaceutical Science and Technology Nov 2018, 72 (6) 626-639; DOI: 10.5731/pdajpst.2018.008615

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations

John D. Ayres

PDA Journal of Pharmaceutical Science and Technology Nov 2018, 72 (6) 626-639; DOI: 10.5731/pdajpst.2018.008615

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Comparing visual inspection methods for parenteral products in hospital pharmacy: between reliability, cost, and operator formation considerations

Google Scholar

Keywords

Particles
Injectables
Clinical Risk Assessment
visual inspection
Patient Safety

Main menu

User menu

Search

Conducting Clinical Risk Assessments for Visible Particulate Matter in Parenteral Preparations

Article Information

Article Versions

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.